Total Payments
$4,327
2024 Payments
$1,412
Companies
14
Transactions
133
Medicare Patients
931
Medicare Billing
$182,920
Payment Breakdown by Category
Food & Beverage$4,280 (98.9%)
Education$46.91 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,280 | 132 | 98.9% |
| Education | $46.91 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,423 | 37 | $0 (2024) |
| Alkermes, Inc. | $1,222 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $418.68 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $304.70 | 6 | $0 (2024) |
| Lundbeck LLC | $173.75 | 11 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $165.00 | 4 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $155.33 | 7 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.00 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $98.38 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $88.09 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 45 | ABBVIE INC. ($542.55) |
| 2023 | $1,378 | 48 | ABBVIE INC. ($480.16) |
| 2022 | $767.37 | 19 | Alkermes, Inc. ($256.58) |
| 2021 | $769.90 | 21 | AbbVie Inc. ($222.89) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $116.99 | General |
| Category: CNS | ||||||
| 11/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: CNS | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Central Nervous System | ||||||
| 09/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.64 | General |
| Category: CNS | ||||||
| 07/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CNS | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Central Nervous System | ||||||
| 06/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: CNS | ||||||
| 06/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $83.66 | General |
| Category: CNS | ||||||
| 06/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 209 | 560 | $197,793 | $37,825 |
| 2022 | 4 | 278 | 702 | $281,167 | $50,727 |
| 2021 | 4 | 250 | 785 | $327,425 | $53,513 |
| 2020 | 3 | 194 | 687 | $301,257 | $40,856 |
Total Patients
931
Total Services
2,734
Medicare Billing
$182,920
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 70 | 380 | $118,940 | $21,846 | 18.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 53 | 60 | $34,020 | $7,384 | 21.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 58 | 65 | $26,325 | $5,444 | 20.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $9,100 | $1,638 | 18.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 42 | $9,408 | $1,512 | 16.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 297 | $127,116 | $21,989 | 17.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 244 | $76,372 | $12,635 | 16.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 70 | 77 | $43,659 | $9,706 | 22.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 74 | 84 | $34,020 | $6,396 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 81 | 453 | $159,429 | $23,902 | 15.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 179 | $76,732 | $13,658 | 17.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 77 | 85 | $59,972 | $10,564 | 17.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 58 | 68 | $31,292 | $5,390 | 17.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 89 | 571 | $216,877 | $30,412 | 14.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 57 | 63 | $54,269 | $6,238 | 11.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 48 | 53 | $30,110 | $4,206 | 14.0% |
About Veronica Jensen, NP
Veronica Jensen, NP is a Psychiatric/Mental Health healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700021391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Veronica Jensen, NP has received a total of $4,327 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 133 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($4,280).
As a Medicare-enrolled provider, Jensen has provided services to 931 Medicare beneficiaries, totaling 2,734 services with total Medicare billing of $182,920. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Piscataway, NJ
- Active Since 12/10/2008
- Last Updated 05/30/2013
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1700021391
Products in Payments
- VRAYLAR (Drug) $1,423
- LYBALVI (Drug) $693.65
- ARISTADA (Drug) $511.53
- INVEGA SUSTENNA (Drug) $304.70
- Austedo XR (Drug) $227.27
- CAPLYTA (Drug) $226.74
- UZEDY (Drug) $191.41
- REXULTI (Drug) $156.15
- LATUDA (Drug) $155.33
- INGREZZA (Drug) $98.38
- ABILIFY MAINTENA (Drug) $74.03
- HETLIOZ (Drug) $40.70
- IGALMI (Drug) $31.98
- ABILIFY ASIMTUFII (Drug) $31.66
- Azstarys (Drug) $18.48
- Vivitrol (Drug) $16.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Piscataway
Laura Stephens-Sutton, Apn, APN
Psychiatric/Mental Health — Payments: $412.45
Psychiatric/Mental Health $412.45
Mr. Anandha Kumar Lakshmanan
Psychiatric/Mental Health — Payments: $117.93
Psychiatric/Mental Health $117.93
Ms. Kathleen Cherwinski, Rn, Apn.c., Mph, Cic, RN, APN.C., MPH, CIC
Psychiatric/Mental Health
Psychiatric/Mental Health
Kimberly Thomas, Rn, RN
Psychiatric/Mental Health
Psychiatric/Mental Health
Ms. Dorothy Schwartz, Rn, Cs, Apn, RN, CS, APN
Psychiatric/Mental Health
Psychiatric/Mental Health
Josette Delapaz, Rn, RN
Psychiatric/Mental Health
Psychiatric/Mental Health